As of 2024-12-13, the Intrinsic Value of Summit Therapeutics Inc (SMMT) is
-0.63 USD. This SMMT valuation is based on the model Peter Lynch Fair Value.
With the current market price of 18.77 USD, the upside of Summit Therapeutics Inc is
-103.35%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-0.63 USD
Intrinsic Value
SMMT Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-0.63 - -0.63 |
-0.63 |
-103.35% |
| P/E |
(2.24) - (2.30) |
(1.88) |
-110.0% |
| DDM - Stable |
(1.00) - (3.51) |
(2.26) |
-112.0% |
| DDM - Multi |
(6.17) - (17.13) |
(9.11) |
-148.5% |
SMMT Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
13,841.94 |
| Beta |
4.24 |
| Outstanding shares (mil) |
737.45 |
| Enterprise Value (mil) |
13,772.66 |
| Market risk premium |
4.60% |
| Cost of Equity |
10.01% |
| Cost of Debt |
5.00% |
| WACC |
9.97% |